Clinical Trial Update: Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing HX575 for chemotherapy-associated anemia in cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• HX575 (epoetin alfa)

Snippet

Sponsor: Sandoz | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2017-08-02